These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma. Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714 [TBL] [Abstract][Full Text] [Related]
28. The side population enriches for leukemia-propagating cell activity and Wnt pathway expression in zebrafish acute lymphoblastic leukemia. Baeten JT; Waarts MR; Pruitt MM; Chan WC; Andrade J; de Jong JLO Haematologica; 2019 Jul; 104(7):1388-1395. PubMed ID: 30630989 [TBL] [Abstract][Full Text] [Related]
29. Investigation of clonal involvement of myeloid cells in Philadelphia-positive and high hyperdiploid acute lymphoblastic leukemia. Kasprzyk A; Harrison CJ; Secker-Walker LM Leukemia; 1999 Dec; 13(12):2000-6. PubMed ID: 10602421 [TBL] [Abstract][Full Text] [Related]
30. Definition of acute biphenotypic leukemia. Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085 [TBL] [Abstract][Full Text] [Related]
31. Effect of myelopoietic and pleiotropic cytokines on colony formation by blast cells of children with acute lymphoblastic leukemia. Benko I; Kovács P; Szegedi I; Megyeri A; Kiss A; Balogh E; Oláh E; Kappelmayer J; Kiss C Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):499-508. PubMed ID: 11383710 [TBL] [Abstract][Full Text] [Related]
32. Pediatric acute lymphoblastic leukemia: there is no TEL-ing what wonders lie ahead. Sandoval C Leuk Res; 2010 Apr; 34(4):418-9. PubMed ID: 19892401 [No Abstract] [Full Text] [Related]
33. [Flow cytometric characterization of maturation processes and primitive stem cell population in pre-B-cell ALL in childhood]. Baersch G; Baumann M; Meltzer J; Möllers T; Ritter J; Jürgens H; Vormoor J Klin Padiatr; 1996; 208(4):160-7. PubMed ID: 8926682 [TBL] [Abstract][Full Text] [Related]
34. Advances in the genetics of high-risk childhood B-progenitor acute lymphoblastic leukemia and juvenile myelomonocytic leukemia: implications for therapy. Loh ML; Mullighan CG Clin Cancer Res; 2012 May; 18(10):2754-67. PubMed ID: 22589484 [TBL] [Abstract][Full Text] [Related]
35. Cancer Stem Cells in the Development of Novel Therapeutics for Refractory Pediatric Leukemia. Brennan L; Narendran A Stem Cells Dev; 2019 Oct; 28(19):1277-1287. PubMed ID: 31364487 [TBL] [Abstract][Full Text] [Related]
36. Recent advances in pediatric acute lymphoblastic and myeloid leukemia. Ravindranath Y Curr Opin Oncol; 2003 Jan; 15(1):23-35. PubMed ID: 12490758 [TBL] [Abstract][Full Text] [Related]